First market launch of the adrenaline nasal spray, EURneffy®, for treatment of adults and children in Germany | ALK

First market launch of the adrenaline nasal spray, EURneffy®, for treatment of adults and children in Germany

Link

https://www.globenewswire.com/news-release/2025/06/26/3105575/0/en/First-market…

Created date

Thu, 06/26/2025 - 12:00

Nasdaq ID

3105575

Last updated: 26.06.2025